SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-22-038903
Filing Date
2022-07-12
Accepted
2022-07-12 17:00:58
Documents
7
Effectiveness Date
2022-07-12

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea162689-s8_oramedpharma.htm S-8 43598
2 OPINION OF SULLIVAN & WORCESTER LLP. ea162689ex5-1_oramedpharma.htm EX-5.1 7564
3 CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea162689ex23-2_oramedpharma.htm EX-23.2 2626
4 FILING FEE TABLE ea162689ex-fee_oramedpharma.htm EX-FILING FEES 17681
5 GRAPHIC ex23-2_001.jpg GRAPHIC 2275
6 GRAPHIC image_001.jpg GRAPHIC 5980
7 GRAPHIC image_002.jpg GRAPHIC 1755
  Complete submission text file 0001213900-22-038903.txt   86889
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266105 | Film No.: 221079633
SIC: 2834 Pharmaceutical Preparations